Innovate VATE Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Total Revenue by Business | |||||
| Infrastructure | $1.21B+12.9% | $1.07B-23.3% | $1.4B-12.4% | $1.59B+37.5% | |
| Life Sciences | $12.5M+27.6% | $9.8M+197% | $3.3M— | —— | |
| Spectrum | $23.2M-9.7% | $25.7M+14.2% | $22.5M-41.9% | $38.7M-7.9% | |
| Other Operating Income by Business | |||||
| Infrastructure | -$1.4M-115% | $9.6M+4,700% | $200K— | —— | |
| Life Sciences | $0— | $0— | $0— | —— | |
| Spectrum | $1M— | —— | $100K— | —— | |
| Income from operations by Business | |||||
| Infrastructure | $55.4M-15.7% | $65.7M+2.0% | $64.4M+12.0% | $57.5M+63.4% | |
| Life Sciences | -$10.9M+22.7% | -$14.1M+6.0% | -$15M— | —— | |
| Cost of revenue by Business | |||||
| Infrastructure | $1.03B+16.6% | $880.4M-26.2% | $1.19B— | —— | |
| Life Sciences | $8.4M+31.3% | $6.4M+146% | $2.6M— | —— | |
| Spectrum | $11.7M+1.7% | $11.5M-2.5% | $11.8M— | —— | |
| Total Assets by Business | |||||
| Infrastructure | $2.85B+2.8% | $2.77B-19.4% | $3.44B-0.1% | $3.45B+12.4% | |
| Life Sciences | $42.1M— | —— | —— | —— | |
| Spectrum | $702.5M-0.5% | $705.9M-1.6% | $717.7M-6.7% | $768.9M-5.6% | |
| Total aggregate finance lease and debt principal payments by Business | |||||
| Infrastructure | $454.2M-30.7% | $655M-27.5% | $903M— | —— | |
| Non-Operating Corporate | $1.82B+5.3% | $1.73B+2.3% | $1.69B— | —— | |
| Spectrum | $278.8M0.0% | $278.8M0.0% | $278.8M— | —— | |
| SG&A by Business | |||||
| Infrastructure | $115.2M-6.4% | $123.1M-2.3% | $126M— | —— | |
| Life Sciences | $14.6M-14.6% | $17.1M+12.5% | $15.2M— | —— | |
| Spectrum | $7.6M+4.1% | $7.3M-18.9% | $9M— | —— | |
| D&A by Business | |||||
| Infrastructure | $12.1M+0.8% | $12M— | —— | $32.3M+69.1% | |
| Life Sciences | $400K0.0% | $400K-20.0% | $500K+66.7% | $300K+50.0% | |
| Spectrum | $5M-2.0% | $5.1M-1.9% | $5.2M-10.3% | $5.8M-3.3% | |
| Investments by Business | |||||
| Infrastructure | $0— | —— | —— | $1M-70.6% | |
| Life Sciences | $7.2M0.0% | $7.2M-69.9% | $23.9M-42.3% | $41.4M— | |
| Spectrum | $0— | —— | —— | —— | |
| Accounts Receivable, before Allowance for Credit Loss, Current by Business | |||||
| Infrastructure | $890.8M+11.3% | $800.7M— | —— | —— | |
| Life Sciences | $8.2M+156% | $3.2M— | —— | —— | |
| Spectrum | $7.1M+6.0% | $6.7M— | —— | —— | |
| Capital cash expenditures by Business | |||||
| Infrastructure | $23.4M+33.0% | $17.6M+6.0% | $16.6M— | —— | |
| Life Sciences | $0— | $0-100% | $500K— | —— | |
| Spectrum | $2.7M+92.9% | $1.4M+40.0% | $1M— | —— | |
| Goodwill by Business | |||||
| Infrastructure | $421.9M0.0% | $422.1M0.0% | $422.3M-0.1% | $422.9M+6.6% | |
| Spectrum | $85.6M0.0% | $85.6M0.0% | $85.6M0.0% | $85.6M0.0% | |
| Revenue by Product | |||||
| Commercial | $371.5M+27.0% | $292.6M-23.6% | $382.9M-51.8% | $794M+47.1% | |
| Convention | $8.9M-36.4% | $14M-88.7% | $124.2M-8.8% | $136.2M+58.7% | |
| Energy | $13.5M+87.5% | $7.2M-21.7% | $9.2M-41.8% | $15.8M— | |
| Government | $128.8M+1,001% | $11.7M+4.5% | $11.2M-67.8% | $34.8M-48.7% | |
| Healthcare | $173.6M+14.5% | $151.6M-8.4% | $165.5M+27.4% | $129.9M+117% | |
| Industrial | $306.6M-0.4% | $307.8M-23.6% | $403M-1.6% | $409.5M+40.0% | |
| Leisure | $12.9M+33.0% | $9.7M+19.8% | $8.1M-65.4% | $23.4M-1.3% | |
| Transportation | $192.8M-30.0% | $275.3M-5.8% | $292.3M+482% | $50.2M-4.7% | |
| Remaining performance obligation amount by Product | |||||
| Commercial | $1.47B+95.6% | $751.7M-7.6% | $813.4M— | —— | |
| Convention | $3.9M-87.8% | $31.9M-82.6% | $183.8M— | —— | |
| Energy | $47.5M+459% | $8.5M— | —— | —— | |
| Government | $586.4M+287% | $151.7M+365% | $32.6M— | —— | |
| Healthcare | $995.2M-25.5% | $1.34B-24.5% | $1.77B— | —— | |
| Industrial | $1.29B+132% | $554.3M-55.9% | $1.26B— | —— | |
| Transportation | $1.41B+107% | $681.3M-45.3% | $1.25B— | —— | |
| Remaining performance obligation period by Product | |||||
| Commercial | $0— | $0— | $0— | $0— | |
| Convention | $0— | $0— | $0— | $0— | |
| Energy | $0— | —— | —— | —— | |
| Government | $0— | $0— | $0— | $0— | |
| Healthcare | $0— | $0— | $0— | $0— | |
| Industrial | $0— | $0— | $0— | —— | |
| Transportation | $0— | $0— | $0— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Innovate break its business down?
- Innovate (VATE) reports total revenue by business across 3 parts — Infrastructure, Life Sciences and Spectrum. Each is extracted from the segment footnotes and tracked over time.
- Where does Innovate's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Innovate's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
